Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This volume is an updated practical guide to the diagnosis and treatment of spasticity, authored by experienced physicians with different specialties. It will help both GPs and specialists, through its provision of a number of tips and tricks to safely provide patients with the most convenient treatment of their spasticity.

Spasticity --- Diagnosis. --- Chemotherapy.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This dissertation by Per Ertzgaard examines the multifaceted approach to spasticity treatment, rooted in rehabilitation medicine. It explores the effects of spasticity within a psychosocial context and evaluates interventions across multiple levels, from understanding spasticity to assessing improvements in movement patterns and life satisfaction. The work includes studies on Goal Attainment Scaling and the validation of portable motion systems, highlighting disparities in access to treatments like Botulinum toxin type A (BoNT-A) in Sweden. The research also evaluates the efficacy of multifocal therapeutic electric stimulation (TES) for spasticity. The intended audience includes medical professionals and researchers in rehabilitation and physical medicine, aiming to improve spasticity management and treatment outcomes.

Spasticity. --- Medical rehabilitation.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Muscles --- Spasticity. --- Physiology. --- Muscle spasticity --- Movement disorders --- Reflexes --- Spasms --- Diseases

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Spasticity, defined as a state of increased muscle tone is not a pathology per se but the direct consequence of the evolution of diverse illnesses, such as spinal cord injuries and multiple sclerosis. The therapeutic value of the baclofène as a treatment for spasticity has been proven. This medicine can be administrated both intrathecally and orally. This two-way administration raises questions about the efficacy, the cost and the practical aspects of each method. On the basis of literature review, we can conclude that intrathecal treatment for spasticity has a medical net value advantage and has fewer side effects. Nevertheless, intrathecal administration of baclofène is limited due to a higher cost and more frequent medical complications. Finally, the intrathecal use of baclofène should be adviced for moderate to severe spasticity, whereas the oral treatment should be administered in case of low spasticity. La spasticité qui se définit comme une tendance d'un muscle à être contracté, n'est pas une pathologie en soi mais bien la conséquence directe de l'évolution de diverses pathologies telles que les lésions médullaires et la sclérose en plaques. Au niveau thérapeutique, l'efficacité du baclofene dans le traitement de la spasticité a clairement été démontrée. Celui-ci pouvant être administré soit par voie orale, soit par voie intrathécale ; des questions se posent quant à leur efficacité respective, leur cout ainsi que leurs aspects pratiques. L'analyse de plusieurs études nous permet ainsi de conclure qu'il y a un net avantage à l'utilisation médicale de la voie intrathécale. Les effets secondaires sont moins fréquents. Néanmoins, l'administration du baclofène par voie intrathécale a un cout supérieur et entraine des complications plus fréquentes, qui en limitent son utilisation. Actuellement, l'administration du baclofène par voie intrathécale est préférée pour traiter la spasticité moyenne à sévère, alors que le traitement par voie orale est à privilégier dans le cas de spasticité légère.

Baclofen --- Injections, Spinal --- Muscle Spasticity

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Infant --- Paralysis --- Child --- Muscle Spasticity